A new five-year study reveals that the evening commute in Delhi delivers the 'worst lung damage of the entire year', ...

Lungpacer Medical announced today that physicians performed the first commercial procedures using its FDA-cleared AeroPace ...

From strengthening the body to aging with grace, the College of Charleston has a new program aimed at promoting long-term ...

Registrational Expansion Cohort (REC) met primary endpoint, demonstrating statistically significant increase in dystrophin to 5.46% at 6 months ...

Air quality will be reduced due to elevated particulate matter which may be unhealthy for sensitive groups. Most people will ...

Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company, announced new data from a post hoc analysis of the Phase 2 eNRGy trial (NCT02912949) evaluating zenocutuzumab in ...

Tessel's contributions to the CATALYST program will accelerate the use of New Approach Methodologies (NAMs) for safer drug development through simulation. This work will also broaden the scope of ...

Retraction notice: paper Left ventricular pseudoaneurysm perceived as a left lung mass [Hafize Yaliniz, Serafettin Demir, Ugur Gocen, Atakan Atalay, Orhan Kemal Salih. Left ventricular pseudoaneurysm ...

Among the diseases that cause dyspnea in felines, primary pulmonary neoplasia is rare and tends to affect senile cats. This study reports the case of a seven teen year old FeLV infected cat who was ...

Activin like kinase 1 (ALK1) mediates signaling via the TGFb family of ligands. ALK1 activity promotes endothelial proliferation and migration. Reduced ALK1 activity is associated with arteriovenous ...

Congenital lung malformations are rare disorders that emerge during a fetus’ development in the womb and are present at birth. Although usually one area of the lung is affected, the malformations can ...

Here, the authors, Barber AG et al, developed a new mouse model and investigated an importance of Musashi-2 in lung cancer. Specifically, they found that Musashi-2 is important for lung cancer cells ...